In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
As of close of business last night, Terns Pharmaceuticals Inc’s stock clocked out at $2.88, up 2.86% from its previous closing price of $2.80. In other words, the price has increased by $2.86 from its previous closing price. On the day, 0.93 million shares were traded.
Ratios:
To gain a deeper understanding of TERN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 23.14 and its Current Ratio is at 23.14. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 31, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $82.
On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.Mizuho initiated its Buy rating on June 22, 2023, with a $16 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 01 ’25 when Kuriakose Emil sold 952 shares for $2.49 per share. The transaction valued at 2,366 led to the insider holds 53,317 shares of the business.
Jung Melita Sun bought 2,250 shares of TERN for $11,498 on Nov 30 ’24. The Chief Business Officer now owns 2,250 shares after completing the transaction at $5.11 per share. On Nov 30 ’24, another insider, Burroughs Amy L., who serves as the Chief Executive Officer of the company, bought 510 shares for $5.11 each. As a result, the insider paid 2,606 and bolstered with 19,609 shares of the company.
Stock Price History:
Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $1.87. The 50-Day Moving Average of the stock is -9.57%, while the 200-Day Moving Average is calculated to be -52.61%.
Shares Statistics:
A total of 87.13M shares are outstanding, with a floating share count of 65.30M. Insiders hold about 25.20% of the company’s shares, while institutions hold 79.11% stake in the company.
